{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T11:53:57Z","timestamp":1777290837118,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"vor","delay-in-days":1008,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX000622"],"award-info":[{"award-number":["BX000622"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 GM103527"],"award-info":[{"award-number":["P30 GM103527"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1194\/jlr.m078204","type":"journal-article","created":{"date-parts":[[2017,9,15]],"date-time":"2017-09-15T01:00:19Z","timestamp":1505437219000},"page":"2264-2274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Prevention of renal apoB retention is protective against diabetic nephropathy: role of TGF-\u03b2 inhibition"],"prefix":"10.1016","volume":"58","author":[{"given":"Patricia G.","family":"Wilson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel C.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghan H.","family":"Yoder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Charnigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa R.","family":"Tannock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1194\/jlr.M078204_bib1","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/archinte.158.9.998","article-title":"Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia","volume":"158","author":"Ravid","year":"1998","journal-title":"Arch. Intern. Med."},{"key":"10.1194\/jlr.M078204_bib2","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/ndt\/12.9.1908","article-title":"Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency","volume":"12","author":"Samuelsson","year":"1997","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1194\/jlr.M078204_bib3","first-page":"127","article-title":"Immunohistological localization of apolipoproteins in the glomeruli in renal disease: specifically apoB and apoE","volume":"36","author":"Sato","year":"1991","journal-title":"Clin. Nephrol."},{"key":"10.1194\/jlr.M078204_bib4","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00125-006-0181-z","article-title":"Proteoglycans can mediate renal lipoprotein retention","volume":"49","author":"Tannock","year":"2006","journal-title":"Diabetologia."},{"key":"10.1194\/jlr.M078204_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.numecd.2011.09.007","article-title":"Retention of atherogenic lipoproteins in the artery wall and its role in atherogenesis","volume":"22","author":"Fogelstrand","year":"2012","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1194\/jlr.M078204_bib6","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2174\/1573399810666140606103645","article-title":"Hyperglycemia to nephropathy via transforming growth factor beta","volume":"10","author":"Garud","year":"2014","journal-title":"Curr. Diabetes Rev."},{"key":"10.1194\/jlr.M078204_bib7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.atherosclerosis.2008.10.017","article-title":"Hypercholesterolemia leads to elevated TGF-beta1 activity and T helper 3-dependent autoimmune responses in atherosclerotic mice","volume":"204","author":"Zhou","year":"2009","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.M078204_bib8","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/ki.1990.35","article-title":"Transforming growth factor-beta regulates production of proteoglycans by mesangial cells","volume":"37","author":"Border","year":"1990","journal-title":"Kidney Int."},{"key":"10.1194\/jlr.M078204_bib9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1681\/ASN.V102271","article-title":"Renal expression of fibrotic matrix proteins and of transforming growth factor-beta (TGF-beta) isoforms in TGF-beta transgenic mice","volume":"10","author":"Mozes","year":"1999","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1194\/jlr.M078204_bib10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2310\/6650.2007.05067","article-title":"Regulation of vascular proteoglycan synthesis by metabolic factors associated with diabetes","volume":"55","author":"Wilson","year":"2007","journal-title":"J. Investig. Med."},{"key":"10.1194\/jlr.M078204_bib11","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.2353\/ajpath.2008.080201","article-title":"SAA, but not CRP, stimulates vascular proteoglycan synthesis in a pro-atherogenic manner","volume":"173","author":"Wilson","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1194\/jlr.M078204_bib12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.biocel.2014.07.020","article-title":"Soluble biglycan as a biomarker of inflammatory renal diseases","volume":"54","author":"Hsieh","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1194\/jlr.M078204_bib13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/0304-4165(95)00183-2","article-title":"Proteoglycans and glycosaminoglycans synthesized in vitro by mesangial cells from normal and diabetic rats","volume":"1290","author":"Hadad","year":"1996","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1194\/jlr.M078204_bib14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1046\/j.1523-1755.2000.00868.x","article-title":"Expression of decorin, biglycan, and collagen type I in human renal fibrosing disease","volume":"57","author":"Stokes","year":"2000","journal-title":"Kidney Int."},{"key":"10.1194\/jlr.M078204_bib15","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1194\/jlr.M002972","article-title":"Reversibility of renal injury with cholesterol lowering in hyperlipidemic diabetic mice","volume":"51","author":"Taneja","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M078204_bib16","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.ajpath.2011.05.016","article-title":"Renal accumulation of biglycan and lipid retention accelerates diabetic nephropathy","volume":"179","author":"Thompson","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1194\/jlr.M078204_bib17","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1016\/j.bbagen.2014.01.035","article-title":"Key roles for the small leucine-rich proteoglycans in renal and pulmonary pathophysiology","volume":"1840","author":"Nastase","year":"2014","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1194\/jlr.M078204_bib18","doi-asserted-by":"crossref","first-page":"812","DOI":"10.2353\/ajpath.2010.090450","article-title":"Biglycan and fibromodulin have essential roles in regulating chondrogenesis and extracellular matrix turnover in temporomandibular joint osteoarthritis","volume":"176","author":"Embree","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1194\/jlr.M078204_bib19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/03008207.2012.715700","article-title":"Decreased body fat, elevated plasma transforming growth factor-beta levels, and impaired BMP4-like signaling in biglycan-deficient mice","volume":"54","author":"Tang","year":"2013","journal-title":"Connect. Tissue Res."},{"issue":"Suppl 4","key":"10.1194\/jlr.M078204_bib20","first-page":"5","article-title":"Decorin deficiency in diabetic mice: aggravation of nephropathy due to overexpression of profibrotic factors, enhanced apoptosis and mononuclear cell infiltration","volume":"60","author":"Merline","year":"2009","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1194\/jlr.M078204_bib21","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.2353\/ajpath.2007.070079","article-title":"Decorin deficiency enhances progressive nephropathy in diabetic mice","volume":"171","author":"Williams","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1194\/jlr.M078204_bib22","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0002-9440(10)64937-1","article-title":"Absence of decorin adversely influences tubulointerstitial fibrosis of the obstructed kidney by enhanced apoptosis and increased inflammatory reaction","volume":"160","author":"Schaefer","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1194\/jlr.M078204_bib23","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.yjmcc.2014.07.014","article-title":"Biglycan deficiency: increased aortic aneurysm formation and lack of atheroprotection","volume":"75","author":"Tang","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1194\/jlr.M078204_bib24","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2337\/diabetes.48.1.182","article-title":"Under control of the Ren-1c promoter, locally produced transforming growth factor-beta1 induces accumulation of glomerular extracellular matrix in transgenic mice","volume":"48","author":"Wogensen","year":"1999","journal-title":"Diabetes."},{"key":"10.1194\/jlr.M078204_bib25","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1194\/jlr.M054015","article-title":"A brief elevation of serum amyloid A is sufficient to increase atherosclerosis","volume":"56","author":"Thompson","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M078204_bib26","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/jphp.12060","article-title":"(S)-[6]-Gingerol inhibits TGF-beta-stimulated biglycan synthesis but not glycosaminoglycan hyperelongation in human vascular smooth muscle cells","volume":"65","author":"Kamato","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1194\/jlr.M078204_bib27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1681\/ASN.V5147","article-title":"Differential growth factor-induced modulation of proteoglycans synthesized by normal human renal versus cyst-derived cells","volume":"5","author":"Kovacs","year":"1994","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1194\/jlr.M078204_bib28","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1161\/01.ATV.13.7.1026","article-title":"Platelet derived growth factor and transforming growth factor-beta 1 differentially affect the synthesis of biglycan and decorin by monkey arterial smooth muscle cells","volume":"13","author":"Sch\u00f6nherr","year":"1993","journal-title":"Arterioscler. Thromb."},{"key":"10.1194\/jlr.M078204_bib29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cytogfr.2005.09.005","article-title":"Role of anti-TGF-beta antibodies in the treatment of renal injury","volume":"17","author":"Gagliardini","year":"2006","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1194\/jlr.M078204_bib30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1684\/ecn.2014.0344","article-title":"Evaluation of renal protective effects of inhibiting TGF-beta type I receptor in a cisplatin-induced nephrotoxicity model","volume":"24","author":"Bayomi","year":"2013","journal-title":"Eur. Cytokine Netw."},{"key":"10.1194\/jlr.M078204_bib31","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1159\/000430222","article-title":"Inhibitory effect of NH4Cl treatment on renal Tgf\u03b21 signaling following unilateral ureteral obstruction","volume":"37","author":"Feger","year":"2015","journal-title":"Cell Physiol. Biochem."},{"key":"10.1194\/jlr.M078204_bib32","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1007\/s00018-014-1798-6","article-title":"EW-7197 inhibits hepatic, renal, and pulmonary fibrosis by blocking TGF-beta\/Smad and ROS signaling","volume":"72","author":"Park","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1194\/jlr.M078204_bib33","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejphar.2014.03.045","article-title":"R-268712, an orally active transforming growth factor-beta type I receptor inhibitor, prevents glomerular sclerosis in a Thy1 nephritis model","volume":"734","author":"Terashima","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1194\/jlr.M078204_bib34","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1159\/000314669","article-title":"Adenovirus-mediated decorin gene transfection has therapeutic effects in a streptozocin-induced diabetic rat model","volume":"116","author":"Zhang","year":"2010","journal-title":"Nephron Exp. Nephrol."},{"key":"10.1194\/jlr.M078204_bib35","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/360361a0","article-title":"Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease","volume":"360","author":"Border","year":"1992","journal-title":"Nature."},{"key":"10.1194\/jlr.M078204_bib36","doi-asserted-by":"crossref","first-page":"30481","DOI":"10.1074\/jbc.M500573200","article-title":"Extracellular matrix proteoglycans control the fate of bone marrow stromal cells","volume":"280","author":"Bi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M078204_bib37","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1753-0407.2010.00089.x","article-title":"Transforming growth factor-beta regulation of proteoglycan synthesis in vascular smooth muscle: contribution to lipid binding and accelerated atherosclerosis in diabetes","volume":"2","author":"Yang","year":"2010","journal-title":"J. Diabetes."},{"key":"10.1194\/jlr.M078204_bib38","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1161\/hq0102.101100","article-title":"Proteoglycans synthesized by arterial smooth muscle cells in the presence of transforming growth factor-beta1 exhibit increased binding to LDLs","volume":"22","author":"Little","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.M078204_bib39","doi-asserted-by":"crossref","first-page":"17640","DOI":"10.1016\/S0021-9258(19)47419-X","article-title":"Effects of platelet-derived growth factor and transforming growth factor, beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells","volume":"266","author":"Sch\u00f6nherr","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M078204_bib40","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1097\/01.ASN.0000074238.61967.B7","article-title":"Add-on anti-TGF-beta antibody to ACE inhibitor arrests progressive diabetic nephropathy in the rat","volume":"14","author":"Benigni","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1194\/jlr.M078204_bib41","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1523-1755.2004.00381.x","article-title":"Divergent effects of low versus high dose anti-TGF-beta antibody in puromycin aminonucleoside nephropathy in rats","volume":"65","author":"Ma","year":"2004","journal-title":"Kidney Int."},{"key":"10.1194\/jlr.M078204_bib42","doi-asserted-by":"crossref","first-page":"8015","DOI":"10.1073\/pnas.120055097","article-title":"Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db\/db diabetic mice","volume":"97","author":"Ziyadeh","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.M078204_bib43","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2169\/internalmedicine.54.3092","article-title":"Risk of chronic kidney disease in non-obese individuals with clustering of metabolic factors: a longitudinal study","volume":"54","author":"Nishikawa","year":"2015","journal-title":"Intern. Med."},{"key":"10.1194\/jlr.M078204_bib44","doi-asserted-by":"crossref","first-page":"83","DOI":"10.5527\/wjn.v4.i1.83","article-title":"Lipid abnormalities in kidney disease and management strategies","volume":"4","author":"Pandya","year":"2015","journal-title":"World J. Nephrol."},{"key":"10.1194\/jlr.M078204_bib45","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1194\/jlr.P040139","article-title":"Prevention of TGFbeta induction attenuates angII-stimulated vascular biglycan and atherosclerosis in Ldlr\u2212\/\u2212 mice","volume":"54","author":"Tang","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M078204_bib46","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cmet.2011.04.013","article-title":"Protection from obesity and diabetes by blockade of TGF-beta\/Smad3 signaling","volume":"14","author":"Yadav","year":"2011","journal-title":"Cell Metab."},{"key":"10.1194\/jlr.M078204_bib47","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/01.ASN.0000042168.43665.9B","article-title":"Therapeutic role of TGF-beta-neutralizing antibody in mouse cyclosporin A nephropathy: morphologic improvement associated with functional preservation","volume":"14","author":"Ling","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1194\/jlr.M078204_bib48","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1002\/jbmr.139","article-title":"Inhibition of TGF-beta signaling by 1D11 antibody treatment increases bone mass and quality in vivo","volume":"25","author":"Edwards","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1194\/jlr.M078204_bib49","doi-asserted-by":"crossref","first-page":"F1291","DOI":"10.1152\/ajprenal.00327.2005","article-title":"Effect of combination therapy with enalapril and the TGF-beta antagonist 1D11 in unilateral ureteral obstruction","volume":"292","author":"El Chaar","year":"2007","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1194\/jlr.M078204_bib50","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520335537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520335537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1194\/jlr.M078204","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T17:31:49Z","timestamp":1637429509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227520335537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0022227520335537"],"URL":"https:\/\/doi.org\/10.1194\/jlr.m078204","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention of renal apoB retention is protective against diabetic nephropathy: role of TGF-\u03b2 inhibition","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1194\/jlr.M078204","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}